Everolimus Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with everolimus
G
- G-1 (acetaminophen / butalbital / caffeine)
- gallium nitrate
- Galzin (zinc acetate)
- Ganite (gallium nitrate)
- Garamycin (gentamicin)
- Gardasil 9 (human papillomavirus vaccine)
- Gastrografin (diatrizoate)
- Gavreto (pralsetinib)
- Gengraf (cyclosporine)
- Genotropin (somatropin)
- Genpril (ibuprofen)
- gentamicin
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Geone (acetaminophen / butalbital / caffeine)
- gepirone
- Gerber Soothe (lactobacillus reuteri)
- Gilenya (fingolimod)
- gilteritinib
- ginger
- Ginger Root (ginger)
- ginger / magnesium sulfate / pyridoxine
- Givlaari (givosiran)
- givosiran
- glasdegib
- glecaprevir / pibrentasvir
- Gleevec (imatinib)
- glimepiride
- glimepiride / pioglitazone
- glimepiride / rosiglitazone
- glipizide
- GlipiZIDE XL (glipizide)
- glipizide / metformin
- glofitamab
- Glucophage (metformin)
- Glucophage XR (metformin)
- Glucotrol (glipizide)
- Glucotrol XL (glipizide)
- Glucovance (glyburide / metformin)
- Glumetza (metformin)
- glyburide
- glyburide / metformin
- glycerol phenylbutyrate
- Glycron (glyburide)
- Glynase (glyburide)
- Glynase PresTab (glyburide)
- Glyset (miglitol)
- Glyxambi (empagliflozin / linagliptin)
- goldenseal
- golimumab
- grepafloxacin
- Grifulvin V (griseofulvin)
- Gris-PEG (griseofulvin)
- Grisactin 250 (griseofulvin)
- Grisactin 500 (griseofulvin)
- Grisactin Ultra (griseofulvin)
- Griseofulicin (griseofulvin)
- Griseofulvic (griseofulvin)
- griseofulvin
- guselkumab
More about everolimus
- everolimus consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.